Chronic Effects of Tendon Vibrations on the Neuromechanical Muscular Properties.
NCT ID: NCT02668224
Last Updated: 2016-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
46 participants
INTERVENTIONAL
2015-02-28
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Short-term Effect of Low-load Resistance Training with Blood-flow Restriction on Somatosensory-evoked Potentials in Healthy Young Adults
NCT06762912
Efficacy of Microcurrent Therapy After Eccentric Exercise
NCT02322489
Applicability and Safety of Vibration Therapy in Intensive Care Unit (ICU) Patients
NCT01286610
Wireless TENS for Peripheral Edema (Lower Limb Swelling)
NCT04680533
Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery
NCT02391103
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Moreover, the last results showed a modification of the nervous capacities of the cortical voluntary activation. Transcranial Magnetic Stimulation (TMS) is a great tool to explore the neuromuscular function, at the cortical stage. The use of this tool will allow the characterization the effects of the vibration training on the cortical activation state.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vibrasens : Test group
Training programme: vibration training 3/week from Day 1 to Day 60 + Usual activities from day 60 to Day 75.
Vibrasens
Transcutaneous vibrations are used. This device allows vibrations from 25 to 150 Hz with an amplitude of 1 mm. In our study the frequency used is 50 Hz.
Control group
Control: Usual activities from day 1 to Day 75.
Usual activities
The patients will perform their usual activities, to allow the comparison with a vibration programme. They will not have a specific training.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vibrasens
Transcutaneous vibrations are used. This device allows vibrations from 25 to 150 Hz with an amplitude of 1 mm. In our study the frequency used is 50 Hz.
Usual activities
The patients will perform their usual activities, to allow the comparison with a vibration programme. They will not have a specific training.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both gender
* Occasional sportsman (\<4h/week)
* Affiliated to a social security scheme
* Having freely given their written consent
Exclusion Criteria
* Contraindication to magnetic field application
* Previous pathologies susceptible to modify the process of the tests (particularly stakeholders presenting knee or ankle pathologies)
* Participation during the same time in another interventional experimentation
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leonard FEASSON, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de SAINT-ETIENNE
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A00036-43
Identifier Type: OTHER
Identifier Source: secondary_id
1408208
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.